Simona Matarese

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

M. Gobbi, N. Colombo, M. Miglino, 2019, British journal of haematology.

Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF).

R. Papa, F. Penco, S. Volpi, 2022, Seminars in arthritis and rheumatism.